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Abstract 
Testicular biopsy may be a component of the work-up of male infertility. However, no reliable 
diagnostic tools are available for objective quantitative assessment of spermatogenic cells. It is 
well known that MAGE-A4 is selectively expressed in spermatogonia and our group has 
previously demonstrated that DOG1 differentially stains germ cells. Therefore, we performed 
DOG1 and a double stain cocktail (DOG1 and 57b murine monoclonal anti-MAGE-A4) 
immunohistochemical stains on 40 testicular fertility biopsies (10 each with active 
spermatogenesis, Sertoli cell-only, hypospermatogenesis, and maturation arrest), 25 benign 
seminiferous tubules from radical orchiectomies, and 5 spermatocytic tumors (ST). In 
biopsies/resections with active spermatogenesis, DOG1 stained spermatocytes and spermatids 
and was absent in spermatogonia, while MAGE-A4 stained spermatogonia and primary 
spermatocytes (weak). In hypospermatogenesis, DOG1 highlighted decreased 
spermatocytes/spermatids and MAGE-A4 highlighted decreased spermatogonia. DOG1 staining 
confirmed decreased to absent spermatocytes in maturation arrest and MAGE-A4 staining 
established the presence of preserved spermatogonia in all cases. All STs were negative for 
DOG1 and positive for MAGE-A4, while all Sertoli cell-only cases were negative for DOG1 and 
the double stain cocktail. In conclusion, we confirmed that DOG1 is expressed in spermatocytes 
and spermatids and MAGE-A4 highlights primarily spermatogonia. Usage of these stains 
facilitates confirmation of maturation arrest, assessment of the percentage of testis involvement 
in hypospermatogenesis and identification of mixed patterns. Finally, this study supports that the 
differentiation of STs is more closely related to spermatogonia than the more mature 
spermatocytes. 
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1. Introduction 
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Interpretation of testicular biopsies is challenging for pathologists because of infrequent 
exposure to these specimens and the lack of objective criteria for assessment of spermatogenic 
cells. Nonetheless, the information gleaned from testicular biopsies has diagnostic, prognostic, 
and therapeutic implications. Therefore, developing a more objective method for assessing these 
specimens is essential to provide actionable information for management.  
DOG1, sometimes referred as Ano1 protein, is a calcium-activated chloride channel 
protein which is expressed in gastrointestinal interstitial cells of Cajal and gastrointestinal 
stromal tumors. 
1-3
 It is encoded by the TMEM16A gene located on chromosome 11q13 
(CCND1-EMS1 locus) and is linked to the regulation of cell survival, proliferation, and 
cholinergic activity of gastrointestinal smooth muscle.
4-6
  Its expression has been demonstrated 
in multiple mesenchymal and nonmesenchymal tumors, including gastrointestinal smooth muscle 
tumors (GIST), pancreatic solid pseudopapillary tumor, chondrosarcoma, and salivary gland 
adenoid cystic carcinoma.
7-13
 While applying DOG1 immunohistochemical stains to orchiectomy 
specimens (resected for germ cell tumors), in a prior study, spermatocytes and spermatids (post-
meiotic forms) showed positive staining while spermatogonia were negative.
14
  
The human MAGE genes are located on the X chromosome in distinct clusters (MAGE-A, 
B, C, and D). They are expressed in a wide variety of tumors and are expressed in a few types of 
normal cells, including; male germ cells, placenta, and possibly cells of the developing 
embryo.
15, 16
 MAGE-1, the Melanoma Associated Antigen family, was originally isolated by van 
der Bruggen in 1991, and recognized as one member of several genes in a cluster collectively 
named MAGE-A.
17
  This discovery led to the development of therapeutic and diagnostic targets 
for different tumor types. MAGE-A4 antigen is strongly expressed in human spermatogonia and 
to a lesser extent in primary spermatocytes and can facilitate their identification and assess their 
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proportion in comparison to other subsets of germ cells.
18, 19
 The antibody 57b directed against 
MAGE-A3 reacts with many members of the MAGE family, including MAGE-A4.
20
 This 
monoclonal antibody (57b) has been the subject of several studies to detect spermatogonia and 
primary spermatocytes in paraffin-embedded testis tissue.
21, 22
 The biologic function of MAGE-
A4 antigen in the testis is not elucidated to date but may be related to cell cycle regulation. We 
evaluated the differential expression patterns of DOG1 and MAGE-A4 in spermatocytes and 
spermatogonia to further characterize the expression patterns in four major histopathologic 
categories of testicular infertility biopsies and investigated the utility of these stains for a more 
objective assessment.  
 
2. Materials and Methods: 
2.1. Tissue Selection: 
A search of the pathology electronic database at Indiana University was performed. Forty 
testicular biopsy specimens from men with azoospermia undergoing an infertility work-up, 25 
cases of benign seminiferous tubules from radical orchiectomy specimens performed for primary 
germ cell neoplasms and 5 spermatocytic tumors were retrieved. The biopsy specimens were 
fixed in Bouin solution and processed routinely using paraffin embedding. Histologic 
examination of spermatogenesis was performed on 4-µM hematoxylin and eosin (H&E) stained 
sections. Based on the H&E findings, the specimens were divided into four groups: normal 
spermatogenesis (n=35; 10 biopsies and 25 resection specimens), Sertoli cell-only (n=10), 
hypospermatogenesis (n=10), and maturation arrest (n=10). Figure 1A-D 
2.2. Immunohistochemical Staining:  
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Immunohistochemical staining for DOG1 (rabbit monoclonal antibody, Cell Marque, CA, 
USA) was performed by using a polymer-based method (En-Vision FLEX or FLEX+; Dako, 
Carpentaria, CA) and diaminobenzidine as the chromogen on a Dako automated immunostaining 
instrument. 
A mouse monoclonal antibody against melanoma antigen family-A4 (MAGE-A4), 57b 
clone (provided by prof. Giulio C. Spagnoli from the University Hospital of Basel, Switzerland) 
was used as a cell supernatant and retrieved in high pH buffer in the PT Module (Dako). It was 
incubated with primary antibody (1:50) for 30 min followed by Flex-hrp (Dako) for 20 minutes, 
then detected with DAB. Positive controls consisted of healthy human testes.  
We evaluated a double stain cocktail using a diamino benzidine (brown chromogen) for 
DOG1 and an aminoethyl-carbazole (red chromogen) for 57b anti-MAGE-A4 for all the fertility 
biopsy cases to assess the performance of the combined stain and its interpretation. DOG1 was 
performed on all cases. MAGE-A4 was performed on 5 spermatocytic tumors. The 
DOG1/MAGE-A4 double cocktail stain was performed on all fertility biopsies. 
Scoring was performed by comparing an estimate of the number of germ cells present on 
H&E slides with a visual estimate of the cells staining positive for DOG1 alone and in 
combination with MAGE-A4. The extent and intensity was scored on a four tiered system (0-
3+). 
3. Results: 
3.1. Normal Spermatogenesis: 
All 10 essentially normal biopsies with active spermatogenesis showed diffuse expression 
of DOG1 in secondary spermatocytes and spermatids versus weak and/or patchy staining in 
primary spermatocytes. Likewise, all 25 resection specimens showed strong DOG1 staining in 
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secondary spermatocytes and spermatids versus rare and weaker staining in primary 
spermatocytes. (Figure 1E and 2A) The double stain cocktail (DOG1 and 57b anti-MAGE-A4) 
showed diffuse staining for the spermatogonia and primary spermatocytes with MAGE-A4 in 
biopsy and resection specimens. (Figure 1F and 2B) DOG1 showed staining in secondary 
spermatocytes, spermatids and spermatozoa with double stain and weak staining in primary 
spermatocytes where it also showed week expression of MAGE-A4. Leydig cells, Sertoli cells, 
interstitial cells, and inflammatory cells were all negative for DOG1 alone and with double stain. 
3.2. Hypospermatogenesis:   
Ten of the ten biopsies assessed for DOG1 expression in the hypospermatogenesis group, 
showed decreased numbers of germ cells in most seminiferous tubules as well as scattered 
partially-stained and completely negative tubules. (Figure 2C)  
The double stain cocktail showed overall decreased number of germ cells. Decreased to 
absent staining for MAGE-A4 (rare/absent spermatogonia) in some tubules and complete loss of 
DOG1 staining (absent spermatocytes/spermatids) in the same areas in all cases, indicating 
diminishing number of mature (secondary spermatocytes/spermatids) germ cells secondary to 
decreased spermatogonia. (Figure 2D) The tubules with relatively active spermatogenesis 
showed a dual staining pattern; with MAGE-A4 highlighting spermatogonia/primary 
spermatocytes and DOG1 staining exhibiting more mature forms including secondary 
spermatocytes and spermatids.   Two cases showed staining for both DOG1 and MAGE-A4 in 
most of the tubules, but the overall number of germ cells was decreased. One case showed a 
preserved number of germ cells in a few tubules confirmed with dual staining, but the remaining 
tubules showed an absence of both stains. Overall, mature forms were found in all the cases, 
albeit in decreased numbers. There was 100% concordance between the overall findings of 
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hypospermatogenesis on the H&E and the double stain cocktail diagnoses in all 10 cases of 
hypospermatogenesis. Furthermore, the double stain results provided additional information in at 
least three cases that suggested a mixed pattern. 
3.3. Maturation Arrest: 
Among the ten biopsies in the maturation arrest group, eight showed differentiation arrest 
at the level of secondary spermatocytes with a severe decrease in the number of more mature 
germ cells (secondary spermatocytes and spermatids) confirmed with DOG1 staining. DOG1 
staining was absent to rare in primary spermatocytes.  The dual cocktail stain showed uniform 
and intense expression of MAGE-A4 in spermatogonia and weak, patchy staining for DOG1 in 
spermatocytes.  One case showed probable arrest at the level of the spermatogonia, since no 
primary spermatocytes were present on DOG1 or the double stain cocktail. One case had mature 
forms when immunohistochemistry was applied, making it more compatible with 
hypospermatogenesis. 
3.4. Sertoli Cell-Only:   
Among the ten cases in the Sertoli cell-only group, all cases showed complete loss of 
staining for DOG1 and the double stain cocktail. This confirms the complete absence of germinal 
epithelium as diagnosed on H&E slides. 
3.5. Spermatocytic Tumors: 
All five spermatocytic tumors were negative for DOG1. MAGE-A4 was diffusely 
positive in the majority of tumor cells in four cases and showed rare, weak staining in the 
remaining case.  
4. Discussion: 
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Testicular biopsies performed during an infertility work-up are challenging specimens 
because of the subjectivity of interpretation, lack of ancillary studies to clarify most findings 
(with the exception of germ cell neoplasia in situ), and infrequency with which most pathologists 
encounter them. Unfortunately, no substantial data exists regarding the concordance of 
interpretation of testicular biopsies between pathologists. In our study, we demonstrate the 
diagnostic utility of immunohistochemical staining for DOG1 and 57B anti-MAGE-A4 
monoclonal antibody (57B MAb) for assessment of testicular biopsies performed during an 
infertility work-up.  
Adequate assessment of a testicular biopsy requires familiarity with the normal histology 
of the testis. In adults, the seminiferous tubules are lined by the spermatogonia and Sertoli cells 
at the periphery. The germinal epithelium matures towards the lumen. Spermatogonia have 
enlarged nuclei and clear cytoplasm. Sertoli cells are oriented perpendicular to the basement 
membrane and have oval to triangular, indented nuclei with prominent nucleoli. In adult males, 
the Sertoli cells constitute approximately 10% of the cells in the seminiferous tubules and are 
mitotically inactive. Primary spermatocytes are characterized by clumped chromatin and cannot 
be differentiated from secondary spermatocytes on light microscopy. Spermatids develop from 
secondary spermatocytes and have prominent tails that extend into the lumen and bullet shaped 
nuclei. On H&E preparations only the nucleus of a spermatid is visible.
23
 A systematic approach 
to the evaluation of all of these components (germinal epithelium, Sertoli cells, Leydig cells, 
interstitium) has been proposed as a method of describing testicular biopsies in pathology 
reports.
24
 
Clinically, azoospermia or oligospermia found on semen analysis can be attributed to 
multiple etiologies, which are categorized as pre-testicular, testicular, and post-testicular. Pre-
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testicular etiologies are usually endocrine in nature. Post-testicular factors are related to duct 
obstruction of the ejaculatory pathway. Testicular factors are primary defects of the testis.
25
 
From the pathologist’s perspective, the histologic patterns encountered on fertility biopsy are 
divided into 7 main categories: normal spermatogenesis, hypospermatogenesis, maturation arrest, 
Sertoli cell-only syndrome, seminiferous tubule hyalinization, germ cell neoplasia in situ, and 
immature/prepubertal testis.
24
 The first four of these patterns are most commonly encountered 
during fertility work up. Normal spermatogenesis is characterized by the presence of all stages of 
maturation in all of the seminiferous tubules. Hypospermatogenesis consists of a variable 
decrease of mature forms. Maturation arrest is characterized by complete absence of maturation 
beyond a specific stage, usually spermatogonial or spermatocytic stage. Sertoli cell-only pattern 
represents tubules lined solely by Sertoli cells without any germinal epithelium.
24, 26
 
Accurate pathologic diagnosis plays a critical role in the diagnosis and treatment of men 
facing reproductive challenges. In patients with azoospermia, normal testicular size, and normal 
follicle-stimulating hormone (FSH) level, biopsy is performed to rule out obstruction. In patients 
with oligospermia, biopsy findings predict the success rate of treatment and which sperm 
retrieval techniques might be utilized. Retrieved spermatozoa can subsequently be used for in-
vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).
27
 Multiple studies have found 
that the histologic pattern found in testicular biopsies submitted for infertility assessment plays a 
significant role in predicting the success rate of spermatozoa recovery, with the best results in 
patients with normal findings and hypospermatogenesis. Patients with seminiferous tubular 
sclerosis, Sertoli cell-only pattern, or maturation arrest have worse outcomes.
28, 29
  
Our results show that DOG1 immunohistochemical staining of paraffin-embedded testis 
tissue is positive in secondary spermatocytes and spermatids, weak/inconsistent in primary 
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spermatocytes, and negative in spermatogonia and Sertoli cells. On the other hand, MAGE-A4 
stains spermatogonia and primary spermatocytes. A double stain cocktail (DOG1 and MAGE-
A4) highlights and allows quantification of the proportionate germinal epithelium at different 
stages of maturation (primary versus secondary), and seminiferous tubules with active 
spermatogenesis. In hypospermatogenesis, early forms (spermatogonia, primary spermatocytes) 
are highlighted in normal numbers at the periphery of the tubules with MAGE-A4 but there is 
decreased DOG1 staining of more mature forms. Maturation arrest shows preserved early forms 
with strong MAGE-A4 staining and negative or extremely rare DOG1 staining of late forms. 
Sertoli cell-only pattern displays complete absence of staining for both markers. The absence of 
DOG1 staining and positivity for MAGE-A4 in spermatocytic tumors suggests that the 
differentiation of these is more closely allied with spermatogonia or primary spermatocyte than 
more mature spermatocytes. This observation has been supported by others as well and it is 
contemplated that MAGE-A4 along with few other antigens link the origin of spermatocytic 
tumor to a premeiotic germ cell, most likely from the spermatogonium. 
18
 
Overall, the application of DOG1 individually or coupled with MAGE-A4 
immunohistochemistry is helpful when assessing testicular biopsies performed for infertility 
work up, these stains provide further support for the histologic findings. Practical applications 
include allowing more accurate quantification of the proportion of affected tubules, identification 
of mixed patterns, and overall more accurate assessment of these infrequently encountered 
specimens. 
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Figure Legend: 
Figure 1: Histologic pattern of testicular biopsies performed for fertility work up with DOC1 and 
MAGE-A4 immunohistochemistry in normal tubules. (A) Normal spermatogenesis, all tubules 
showing spermatogonia, spermatocytes and spermatids along with Sertoli cells and normal 
Leydig cells in interstitium. Notice no thickening of basement membranes. (B) 
Hypospermatogenesis; seminiferous tabules displaying decreased spermatogenesis; however, all 
cell types are present albeit in decreased numbers. (C) Maturation arrest; tubules only displaying 
predominantly spermatogonia without mature forms. (D) Sertoli cell pattern exhibiting only 
Sertoli cells and thickened basement membranes. (E) Immunohistochemistry for DOG1 in active 
spermatogenesis (X400), Nonstaining cells (asterisks) at the basement membrane represent 
spermatogonia, red arrow indicates primary spermatocyte, blue arrow indicates secondary 
spermatocyte and the black arrow indicates a spermatid. (F) Immunohistochemical double 
cocktail stain for MAGE-A4 and DOG1 in active spermatogenesis (X400). Black arrow show 
spermatogonia with strong expression and white arrow represent primary spermatocyte with 
weak staining for MAGE-A4 (red chromogen). Secondary spermatocytes are highlighted by 
DOG1 in (brown chromogen, blue arrow). Few spermatocytes expressed weak dual staining with 
DOG1 and MAGE-A4 (brown arrow). 
 
Figure 2: Immunohistochemical expression for DOG1 (brown) and MAGE-A4 (red chromogen) 
in testicular biopsies. (A) DOG1 expression in active spermatogenesis. (B)  Dual staining in 
active spermatogenesis. (C) DOG1 staining in hypospermatogenesis. (D) Dual staining in 
hypospermatogenesis. (E) DOG1 staining in maturation arrest. (F) Dual staining in maturation 
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arrest. (G) DOG1 staining in sertoli cell only pattern. (H) Dual staining in Sertoli cell only 
pattern.  
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Highlights: 
- MAGE-A4 and/or DOG1 provide support for the histologic findings 
- Applications allow more accurate quantification of affected tubules 
- Applications allow identification of mixed patterns 
- Applications allow more accurate assessment of these specimens. 
ACCEPTED MANUSCRIPT
Downloaded for Anonymous User (n/a) at Indiana University - Ruth Lilly Medical Library from ClinicalKey.com by Elsevier on February 26, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
Figure 1
 Downloaded for Anonymous User (n/a) at Indiana University - Ruth Lilly Medical Library from ClinicalKey.com by
 Elsevier on February 26, 2019. For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All
 rights reserved.
Figure 2
 Downloaded for Anonymous User (n/a) at Indiana University - Ruth Lilly Medical Library from ClinicalKey.com by
 Elsevier on February 26, 2019. For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All
 rights reserved.
